EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study

Ángela Sánchez-Simarro, Eliseo Albert, Estela Giménez iD, Ester Colomer, Ariadna Pérez, José Luis Piñana iD, Carlos Solano, David Navarro iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Ángela Sánchez-Simarro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Interleukin-10, Cytomegalovirus, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated whether plasma cytomegalovirus (CMV) IL‐10 (cmvIL‐10) levels could serve as a biomarker of active CMV replication in allogeneic hematopoietic transplant recipients (allo‐HCT) in the presence or absence of letermovir (LMV) prophylaxis. A total of 189 leftover plasma samples that tested positive for CMV DNA (Alinity m CMV assay), representing 33 episodes of CMV DNAemia were run on a laboratory‐developed enzyme‐linked immunosorbent assay for cmvIL‐10 quantification. Eighteen episodes developed during LMV prophylaxis. Overall, 16 episodes of CMV DNAemia were classified as clinically significant (CsCMVi). There was an overall very weak correlation between the two biomarkers (Rho = 0.10; p = 0.16). Overall, the median cmvIL‐10 area under the curve (AUC) until CMV DNA levels reached their peak was significantly higher ( p < 0.001) in CsCMVi episodes than in non‐CsCMVi episodes. cmvIL‐10 AUC between Days 14 and 23 after allo‐HCT (AUC₁₄₋₂₃) values were significantly higher in CsCMVi episodes compared with non‐CsCMVi episodes among patients receiving LMV therapy ( p = 0.008). An AUC₁₄₋₂₃ cutoff value of log 10 3.06 discriminated anticipately between CsCMVi and non‐CsCMVi with a sensitivity and specificity of 100%. Plasma cmvIL‐10 levels may reflect true CMV replication and thus provide a unique perspective on viral dynamics, serving as an ancillary marker to CMV DNA monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsInterleukin-10CytomegalovirusHematopoietic Stem Cell TransplantationBiomarkersTransplant RecipientsPlasmaHumansFemaleDNA, ViralAntiviral AgentsMaleMiddle AgedAdultTransplantation, HomologousQuinazolinesAcetatesEnzyme-Linked Immunosorbent AssayAgedYoung Adult

Stichwörter der Autor:innen

CMV DNAemiaactive CMV infectionallogeneic hematopoietic stem cell transplantationcmvIL‐10cytomegalovirus (CMV)

Substanzen

Interleukin-10BiomarkersDNA, ViralAntiviral AgentsletermovirQuinazolinesAcetatesIL10 protein, human

Autor:innen und Institutionen

  • Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Hematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
  • Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.

ORCID-Profile: Estela Giménez, José Luis Piñana, David Navarro

Zitieren

APA

Sánchez-Simarro, Á., Albert, E., Giménez, E., Colomer, E., Pérez, A., Piñana, J. L., Solano, C., & Navarro, D. (2026). Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70806

Vancouver

Sánchez-Simarro Á, Albert E, Giménez E, Colomer E, Pérez A, Piñana JL, et al. Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study. Journal of Medical Virology. 2026. doi:10.1002/jmv.70806

BibTeX
@article{SnchezSimarro2026,
  author = {Sánchez-Simarro, Ángela and Albert, Eliseo and Giménez, Estela and Colomer, Ester and Pérez, Ariadna and Piñana, José Luis and Solano, Carlos and Navarro, David},
  title = {Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70806}
}
Kostenlos starten →